Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Multiple Sclerosis

  Free Subscription


Articles published in Ann Neurol

Retrieve available abstracts of 41 articles:
HTML format
Text format



Single Articles


    April 2017
  1. SELMAJ I, Cichalewska M, Namiecinska M, Galazka G, et al
    Global Exosome Transcriptome Profiling Reveals Biomarkers for Multiple Sclerosis.
    Ann Neurol. 2017 Apr 15. doi: 10.1002/ana.24931.
    PubMed     Text format     Abstract available


    December 2016
  2. HERRANZ E, Hooker JM, Izquierdo-Garcia D, Loggia ML, et al
    11 C-PBR28 increase in multiple sclerosis reflects neuroinflammation.
    Ann Neurol. 2016 Dec 29. doi: 10.1002/ana.24865.
    PubMed     Text format    


  3. RAFFEL J, Sridharan S, Nicholas R
    [11 C]PBR-28 PET in multiple sclerosis: Neuroinflammation or otherwise?
    Ann Neurol. 2016 Dec 26. doi: 10.1002/ana.24853.
    PubMed     Text format    


    October 2016
  4. GOBEL K, Kraft P, Pankratz S, Gross CC, et al
    Prothrombin and factor X are elevated in multiple sclerosis patients.
    Ann Neurol. 2016 Oct 24. doi: 10.1002/ana.24807.
    PubMed     Text format     Abstract available


    September 2016
  5. HERRANZ E, Gianni C, Louapre C, Treaba CA, et al
    The neuroinflammatory component of gray matter pathology in multiple sclerosis.
    Ann Neurol. 2016 Sep 30. doi: 10.1002/ana.24791.
    PubMed     Text format     Abstract available


    August 2016
  6. CORTESE M, Riise T, Bjornevik K, Bhan A, et al
    Pre-clinical disease activity in multiple sclerosis- a prospective study on cognitive performance prior to first symptom.
    Ann Neurol. 2016 Aug 23. doi: 10.1002/ana.24769.
    PubMed     Text format     Abstract available


    July 2016
  7. CREE B, Gourraud PA, Oksenberg JR, Bevan C, et al
    Long-term evolution of multiple sclerosis disability in the treatment era.
    Ann Neurol. 2016 Jul 27. doi: 10.1002/ana.24747.
    PubMed     Text format     Abstract available


  8. WINDER K, Linker RA, Seifert F, Deutsch M, et al
    Neuroanatomic Correlates of Female Sexual Dysfunction in Multiple Sclerosis.
    Ann Neurol. 2016 Jul 27. doi: 10.1002/ana.24746.
    PubMed     Text format     Abstract available


    June 2016
  9. GERDES LA, Held K, Beltran E, Berking C, et al
    CTLA-4 as immunological checkpoint in the development of multiple sclerosis.
    Ann Neurol. 2016 Jun 28. doi: 10.1002/ana.24715.
    PubMed     Text format     Abstract available


    May 2016
  10. JOKUBAITIS VG, Spelman T, Kalincik T, Lorscheider J, et al
    Predictors of long-term disability accrual in relapse-onset multiple sclerosis.
    Ann Neurol. 2016 May 4. doi: 10.1002/ana.24682.
    PubMed     Text format     Abstract available


    April 2016
  11. BODINI B, Veronese M, Turkheimer F, Stankoff B, et al
    Benzothiazole and stilbene derivatives as promising PET myelin radiotracers for multiple sclerosis.
    Ann Neurol. 2016 Apr 21. doi: 10.1002/ana.24667.
    PubMed     Text format    


  12. MATIAS-GUIU JA, Cabrera-Martin MN, Oreja-Guevara C, Carreras JL, et al
    PiB and other amyloid-PET tracers for the study of white matter and multiple sclerosis.
    Ann Neurol. 2016 Apr 21. doi: 10.1002/ana.24666.
    PubMed     Text format    


  13. HOKARI M, Yokoseki A, Arakawa M, Saji E, et al
    Clinicopathological features in anterior visual pathway in neuromyelitis optica.
    Ann Neurol. 2016;79:605-24.
    PubMed     Text format     Abstract available


    March 2016
  14. ALPING P, Frisell T, Novakova L, Islam-Jakobsson P, et al
    Rituximab versus fingolimod after natalizumab in multiple sclerosis patients.
    Ann Neurol. 2016 Mar 31. doi: 10.1002/ana.24651.
    PubMed     Text format     Abstract available


  15. LASSMANN H
    Demyelination and Neurodegeneration in Multiple Sclerosis: The Role of Hypoxia.
    Ann Neurol. 2016 Mar 9. doi: 10.1002/ana.24632.
    PubMed     Text format    


  16. JELCIC I, Jelcic I, Kempf C, Largey F, et al
    Mechanisms of immune escape in central nervous system infection with neurotropic JC virus variant.
    Ann Neurol. 2016;79:404-18.
    PubMed     Text format     Abstract available


    February 2016
  17. BODINI B, Veronese M, Garcia-Lorenzo D, Battaglini M, et al
    Dynamic imaging of individual remyelination profiles in multiple sclerosis.
    Ann Neurol. 2016 Feb 18. doi: 10.1002/ana.24620.
    PubMed     Text format     Abstract available


    January 2016
  18. DESAI RA, Davies AL, Tachrount M, Kasti M, et al
    Cause and prevention of demyelination in a model multiple sclerosis lesion.
    Ann Neurol. 2016 Jan 27. doi: 10.1002/ana.24607.
    PubMed     Text format     Abstract available


    November 2015
  19. KANTARCI OH, Lebrun C, Siva A, Keegan MB, et al
    Primary Progressive MS evolving from Radiologically Isolated Syndrome.
    Ann Neurol. 2015 Nov 24. doi: 10.1002/ana.24564.
    PubMed     Text format     Abstract available


  20. XIA Z, White CC, Owen EK, Von Korff A, et al
    GEMS Project: A Platform to Investigate Multiple Sclerosis Risk.
    Ann Neurol. 2015 Nov 19. doi: 10.1002/ana.24560.
    PubMed     Text format     Abstract available


  21. SAIDHA S, Al-Louzi O, Ratchford JN, Bhargava P, et al
    Optical coherence tomography reflects brain atrophy in multiple sclerosis: A four-year study.
    Ann Neurol. 2015;78:801-13.
    PubMed     Text format     Abstract available


    October 2015
  22. CASTILLO-GOMEZ E, Kastner A, Steiner J, Schneider A, et al
    The brain as 'immunoprecipitator' of serum autoantibodies against NMDAR1.
    Ann Neurol. 2015 Oct 27. doi: 10.1002/ana.24545.
    PubMed     Text format     Abstract available


    August 2015
  23. SATO S, Yamamoto K, Matsushita T, Isobe N, et al
    Copy number variations in multiple sclerosis and neuromyelitis optica.
    Ann Neurol. 2015 Aug 21. doi: 10.1002/ana.24511.
    PubMed     Text format     Abstract available


  24. FREEMAN L, Garcia-Lorenzo D, Bottin L, Leroy C, et al
    The neuronal component of gray matter damage in multiple sclerosis: A [ C]flumazenil positron emission tomography study.
    Ann Neurol. 2015 Aug 21. doi: 10.1002/ana.24468.
    PubMed     Text format     Abstract available


  25. FRISCHER JM, Weigand SD, Guo Y, Kale N, et al
    Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque.
    Ann Neurol. 2015 Aug 3. doi: 10.1002/ana.24497.
    PubMed     Text format     Abstract available


    July 2015
  26. LAROCHELLE C, Lecuyer MA, Alvarez JI, Charabati M, et al
    Melanoma cell adhesion molecule-positive CD8 T lymphocytes mediate central nervous system inflammation.
    Ann Neurol. 2015;78:39-53.
    PubMed     Text format     Abstract available


    June 2015
  27. JEHNA M, Pirpamer L, Khalil M, Fuchs S, et al
    Periventricular lesions correlate with cortical thinning in multiple sclerosis.
    Ann Neurol. 2015 Jun 18. doi: 10.1002/ana.24461.
    PubMed     Text format     Abstract available


    April 2015
  28. ESPOSITO F, Sorosina M, Ottoboni L, Lim ET, et al
    A pharmacogenetic study implicates SLC9A9 in multiple sclerosis disease activity.
    Ann Neurol. 2015 Apr 25. doi: 10.1002/ana.24429.
    PubMed     Text format     Abstract available


    March 2015
  29. HEUSSINGER N, Kontopantelis E, Gburek-Augustat J, Jenke A, et al
    Oligoclonal bands predict multiple sclerosis in children with optic neuritis.
    Ann Neurol. 2015 Mar 26. doi: 10.1002/ana.24409.
    PubMed     Text format     Abstract available


  30. KOMORI M, Blake A, Greenwood M, Lin YC, et al
    CSF markers reveal intrathecal inflammation in progressive multiple sclerosis.
    Ann Neurol. 2015 Mar 25. doi: 10.1002/ana.24408.
    PubMed     Text format     Abstract available


  31. VILLAR LM, Costa-Frossard L, Masterman T, Fernandez O, et al
    Lipid-specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with natalizumab.
    Ann Neurol. 2015;77:447-57.
    PubMed     Text format     Abstract available


    February 2015
  32. MICHAILIDOU I, Willems JG, Kooi EJ, van Eden C, et al
    Complement C1q-C3 associated synaptic changes in multiple sclerosis hippocampus.
    Ann Neurol. 2015 Feb 27. doi: 10.1002/ana.24398.
    PubMed     Text format     Abstract available


    January 2015
  33. PFEIFENBRING S, Bunyan RF, Metz I, Rover C, et al
    Extensive acute axonal damage in pediatric multiple sclerosis lesions.
    Ann Neurol. 2015 Jan 21. doi: 10.1002/ana.24364.
    PubMed     Text format     Abstract available


    December 2014
  34. KALINCIK T, Horakova D, Spelman T, Jokubaitis V, et al
    Switch to natalizumab vs fingolimod in active relapsing-remitting multiple sclerosis.
    Ann Neurol. 2014 Dec 27. doi: 10.1002/ana.24339.
    PubMed     Text format     Abstract available


  35. WARNKE C, von Geldern G, Markwerth P, Dehmel T, et al
    Cerebrospinal fluid JC virus antibody index for diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy.
    Ann Neurol. 2014;76:792-801.
    PubMed     Text format     Abstract available


    November 2014
  36. KIMBROUGH DJ, Sotirchos ES, Wilson JA, Al-Louzi O, et al
    Retinal Damage and Vision Loss in African-American Multiple Sclerosis Patients.
    Ann Neurol. 2014 Nov 8. doi: 10.1002/ana.24308.
    PubMed     Text format     Abstract available


    September 2014
  37. ASCHERIO A, Munger KL
    Not too late to take vitamin D supplements.
    Ann Neurol. 2014;76:321-2.
    PubMed     Text format    


  38. COLOMBO E, Di Dario M, Capitolo E, Chaabane L, et al
    Fingolimod may support neuroprotection via blockade of astrocyte nitric oxide.
    Ann Neurol. 2014;76:325-37.
    PubMed     Text format     Abstract available


    August 2014
  39. SATO DK, Callegaro D, de Haidar Jorge FM, Nakashima I, et al
    Cerebrospinal fluid aquaporin-4 antibody levels in neuromyelitis optica attacks.
    Ann Neurol. 2014;76:305-9.
    PubMed     Text format     Abstract available


  40. VILLAR LM, Casanova B, Ouamara N, Comabella M, et al
    Immunoglobulin M oligoclonal bands: biomarker of targetable inflammation in primary progressive multiple sclerosis.
    Ann Neurol. 2014;76:231-40.
    PubMed     Text format     Abstract available


    July 2014
  41. LIU W, Nair G, Vuolo L, Bakshi A, et al
    In vivo imaging of spinal cord atrophy in neuroinflammatory diseases.
    Ann Neurol. 2014 Jul 4. doi: 10.1002/ana.24213.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: